Share this article SELBYVILLE, Del., Jan. 20, 2021 /PRNewswire/ -- According to latest report "U.S. Cannabis Testing Market by Technology (Chromatography, Spectroscopy), Test Type (Potency Testing, Pesticide Screening, Residual Solvent Screening, Heavy Metal Testing, Terpene Testing, Mycotoxin Testing), Zonal Outlook, Price Trends, Competitive Market Share & Forecast 2027", by Global Market Insights, Inc., the market valuation of cannabis testing in the United States will cross $4.1 billion by 2027. U.S. cannabis testing market for liquid chromatography (LC) segment exceeded USD 662.4 million in 2020 due to half of the cannabis testing procedures are completed through LC. Stringent regulatory policies to ensure the availability of high-quality cannabis for the treatment of various medical conditions and recreational use will spur the demand for U.S. cannabis testing services during the forecast timeframe. Moreover, the FDA has several resources available that address cannabis such as CBD, and the agency wants to ensure that stakeholders and consumers have access to these resources in a centralized location. For instance, the FDA is committed to working with State, Local, Tribal, Territorial (SLTT) Regulatory Officials for testing and commercialization of medical and adult-use cannabis across various states of the U.S.